Thomas M. Siler

The Safety and Efficacy of Infliximab in Moderate to Severe Chronic Obstructive Pulmonary Disease

Stephen I. Rennard, Charles Fogarty, Steven G. Kelsen et al. · American Journal of Respiratory and Critical Care Medicine · 2007 · 432 citations

Medicine, Clinical Sciences, Pharmacotherapy +16

Ensifentrine, a Novel Phosphodiesterase 3 and 4 Inhibitor for the Treatment of Chronic Obstructive Pulmonary Disease: Randomized, Double-Blind, Placebo-controlled, Multicenter Phase III Trials (the ENHANCE Trials)

Antonio Anzueto, Igor Barjaktarević, Thomas M. Siler et al. · American Journal of Respiratory and Critical Care Medicine · 2023 · 146 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Efficacy and safety of indacaterol 150 μg once-daily in COPD: a double-blind, randomised, 12-week study

Gregory Feldman, Thomas M. Siler, Niyati Prasad et al. · BMC Pulmonary Medicine · 2010 · 119 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Efficacy and Safety of Glycopyrrolate/Formoterol Metered Dose Inhaler Formulated Using Co-Suspension Delivery Technology in Patients With COPD

Fernando J. Martínez, Klaus F. Rabe, Gary T. Ferguson et al. · CHEST Journal · 2016 · 104 citations · Full text

Pharmacy, Clinical Sciences, Pharmacotherapy +10

Immunoreactive Interleukin-1 in Bronchoalveolar Lavage Fluid of High-Risk Patients and Patients with the Adult Respiratory Distress Syndrome

Thomas M. Siler, James E. Swierkosz, Thomas M. Hyers et al. · Experimental Lung Research · 1989 · 84 citations

Veterinary Medicine, Immunology, Pathology +17